MA55083A - Polyribonucléotides et leurs utilisations cosmétiques - Google Patents

Polyribonucléotides et leurs utilisations cosmétiques

Info

Publication number
MA55083A
MA55083A MA055083A MA55083A MA55083A MA 55083 A MA55083 A MA 55083A MA 055083 A MA055083 A MA 055083A MA 55083 A MA55083 A MA 55083A MA 55083 A MA55083 A MA 55083A
Authority
MA
Morocco
Prior art keywords
polyribonucleotides
cosmetic uses
cosmetic
Prior art date
Application number
MA055083A
Other languages
English (en)
Inventor
Ellese Marie Carmona
Boer Alexandra Sophie De
Avak Kahvejian
Nicholas Mccartney Plugis
Morag Helen Stewart
Original Assignee
Flagship Pioneering Innovations Vi Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Innovations Vi Llc filed Critical Flagship Pioneering Innovations Vi Llc
Publication of MA55083A publication Critical patent/MA55083A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D37/00—Sachet pads specially adapted for liquid toiletry or cosmetic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D2200/00—Details not otherwise provided for in A45D
    • A45D2200/10—Details of applicators
    • A45D2200/1009—Applicators comprising a pad, tissue, sponge, or the like
    • A45D2200/1018—Applicators comprising a pad, tissue, sponge, or the like comprising a pad, i.e. a cushion-like mass of soft material, with or without gripping means
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D2200/00—Details not otherwise provided for in A45D
    • A45D2200/25—Kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA055083A 2019-03-01 2020-03-01 Polyribonucléotides et leurs utilisations cosmétiques MA55083A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962812772P 2019-03-01 2019-03-01

Publications (1)

Publication Number Publication Date
MA55083A true MA55083A (fr) 2022-03-16

Family

ID=70050204

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055083A MA55083A (fr) 2019-03-01 2020-03-01 Polyribonucléotides et leurs utilisations cosmétiques

Country Status (13)

Country Link
US (1) US20220142896A1 (fr)
EP (1) EP3930676B1 (fr)
JP (2) JP7614108B2 (fr)
KR (1) KR102901623B1 (fr)
CN (1) CN113543766A (fr)
AU (1) AU2020232238B2 (fr)
CA (1) CA3128644A1 (fr)
DK (1) DK3930676T3 (fr)
ES (1) ES2928724T3 (fr)
IL (2) IL311628A (fr)
MA (1) MA55083A (fr)
PL (1) PL3930676T3 (fr)
WO (1) WO2020180752A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020011670A2 (pt) 2017-12-15 2020-11-17 Flagship Pioneering Innovations Vi, Llc. composições compreendendo polirribonucleotídeos circulares e seus usos
CA3131319A1 (fr) 2019-03-25 2020-10-01 Avak Kahvejian Compositions comprenant des polyribonucleotides circulaires modifies et utilisations associees
US11484077B1 (en) * 2019-10-08 2022-11-01 Mea Madamba Arsenault Combination storage and sterilization device for fake eyelashes
EP4153152A1 (fr) * 2020-05-20 2023-03-29 Flagship Pioneering Innovations VI, LLC Compositions et procédés de production d'anticorps polyclonaux humains
CN112481289B (zh) 2020-12-04 2023-06-27 苏州科锐迈德生物医药科技有限公司 一种转录环状rna的重组核酸分子及其在蛋白表达中的应用
US20220202162A1 (en) * 2020-12-31 2022-06-30 Millenia Productions, Llc Basin containing individually packaged spa products for use therewith
AR127073A1 (es) 2021-09-17 2023-12-13 Flagship Pioneering Innovations Vi Llc Composiciones y métodos para producir polirribonucleótidos circulares
IL312965A (en) 2021-11-24 2024-07-01 Flagship Pioneering Innovations Vi Llc Immunogenic compositions and their uses
JP2024541466A (ja) 2021-11-24 2024-11-08 フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー 水痘帯状疱疹ウイルス免疫原組成物及びその使用
JP2024541467A (ja) 2021-11-24 2024-11-08 フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー コロナウイルス免疫原組成物及びそれらの使用
AU2022413687A1 (en) 2021-12-17 2024-06-27 Flagship Pioneering Innovations Vi, Llc Methods for enrichment of circular rna under denaturing conditions
JP2025500358A (ja) 2021-12-23 2025-01-09 フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー 抗膜融合ポリペプチドをコードする環状ポリリボヌクレオチド
CN115992103B (zh) * 2022-12-20 2025-09-02 深圳瑞德林生物技术有限公司 酶突变体及类蛇毒三肽的制备方法
WO2024159172A1 (fr) 2023-01-27 2024-08-02 Senda Biosciences, Inc. Composition lipidique modifiée et ses utilisations
CN121358494A (zh) 2023-03-15 2026-01-16 旗舰创业创新第六有限责任公司 免疫原性组合物及其用途
KR20250162610A (ko) 2023-03-15 2025-11-18 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 폴리리보뉴클레오티드를 포함하는 조성물 및 이의 용도
WO2025006684A1 (fr) 2023-06-28 2025-01-02 Flagship Pioneering Innovations Vi, Llc Polyribonucléotides circulaires codant pour des polypeptides antifusogènes
KR102814689B1 (ko) * 2023-12-15 2025-05-29 주식회사 파마리서치 Dna 단편 혼합물 및 다가 알코올을 포함하는 조직 수복용 생체 재료 조성물
KR102907856B1 (ko) 2025-01-21 2026-01-08 (주) 옵트바이오 프로바이오틱스 유래 폴리리보뉴클레오티드를 유효성분으로 포함하는 안티에이징 화장료 조성물
CN119656055A (zh) * 2025-02-21 2025-03-21 恒昱生物制药(山东)有限公司 含pn和透明质酸钠的修复组合物及其制备方法和应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1222701B (it) * 1987-09-23 1990-09-12 Crinos Industria Farmaco Composizione ad uso topico avente attivita' tricogena,antiforfora ed antiseborroica
JP2796990B2 (ja) 1989-05-10 1998-09-10 株式会社資生堂 肌用化粧料
CA2087256A1 (fr) 1990-07-25 1992-01-26 Jerry L. Ruth Extension circulaire pour produire des complements multiples d'acides nucleiques
US5426180A (en) 1991-03-27 1995-06-20 Research Corporation Technologies, Inc. Methods of making single-stranded circular oligonucleotides
US5877160A (en) * 1991-05-31 1999-03-02 Genta Incorporated Compositions and methods of treatment of androgen-associated baldness using antisense oligomers
WO1993014218A1 (fr) 1992-01-13 1993-07-22 Duke University Molecules d'arn enzymatiques
US5773244A (en) 1993-05-19 1998-06-30 Regents Of The University Of California Methods of making circular RNA
US5766903A (en) * 1995-08-23 1998-06-16 University Technology Corporation Circular RNA and uses thereof
US6797276B1 (en) * 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US6210931B1 (en) 1998-11-30 2001-04-03 The United States Of America As Represented By The Secretary Of Agriculture Ribozyme-mediated synthesis of circular RNA
DE102004025881A1 (de) * 2004-05-19 2006-01-05 Beiersdorf Ag Oligoribonukleotide zur Beeinflussung des Haarwachstums
JP2008513513A (ja) * 2004-09-21 2008-05-01 アネシヴァ， インコーポレイテッド ポリヌクレオチドの送達
DE102005001784A1 (de) * 2005-01-13 2006-10-05 Beiersdorf Ag Oligoribonukleotide zur Reduktion der Schweißbildung durch RNA-Interferenz
FR2885808B1 (fr) * 2005-05-19 2007-07-06 Oreal Vectorisation de dsrna par des particules cationiques et utilisation topique.
DE102005046490A1 (de) 2005-09-28 2007-03-29 Johannes-Gutenberg-Universität Mainz Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
WO2007069068A2 (fr) 2005-12-16 2007-06-21 Diatos Conjugués peptidiques de pénétration cellulaire pour la délivrance d'acides nucléiques dans une cellule
WO2007097561A1 (fr) 2006-02-20 2007-08-30 Ewha University - Industry Collaboration Foundation Peptide présentant une activité de pénétration de membrane cellulaire
JP5025253B2 (ja) 2006-03-31 2012-09-12 日生バイオ株式会社 基礎化粧品用配合剤及び基礎化粧品
US20080153741A1 (en) * 2006-12-21 2008-06-26 Nissei Bio Co., Ltd. Compounding ingredients for cosmetic formulation for improving skinditch density and cosmetic
JP5296328B2 (ja) 2007-05-09 2013-09-25 独立行政法人理化学研究所 １本鎖環状ｒｎａおよびその製造方法
WO2010084371A1 (fr) 2009-01-26 2010-07-29 Mitoprod Nouvelles molécules d'arn interférent circulaire
SG186347A1 (en) 2010-06-14 2013-01-30 Hoffmann La Roche Cell-penetrating peptides and uses therof
KR101186130B1 (ko) * 2010-08-10 2012-09-27 (주)다미화학 니코틴산 아데닌 디뉴클레오티드 인산 또는 그의 유도체를 포함하는 약학적 또는 화장료 조성물
SMT202200311T1 (it) 2010-08-31 2022-09-14 Glaxosmithkline Biologicals Sa Liposomi pegilati per somministrare rna codificante un immunogene
KR101938548B1 (ko) * 2011-06-23 2019-01-15 (주)아모레퍼시픽 마이크로 ｒｎａ를 포함하는 색소형성유전자 발현조절용 조성물
US20140141070A1 (en) 2011-07-06 2014-05-22 Andrew Geall Liposomes having useful n:p ratio for delivery of rna molecules
EP2765982A1 (fr) * 2011-10-11 2014-08-20 Hans Kosak Diméthylsulfoxyde utilisé comme solvant pour des acides nucléiques
US9039967B2 (en) * 2012-02-06 2015-05-26 Hyprotek, Inc. Antiseptic applicators and packaging techniques
EP2834259A4 (fr) * 2012-04-02 2016-08-24 Moderna Therapeutics Inc Polynucléotides modifiés
US9254311B2 (en) * 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
DE102013005361A1 (de) * 2013-03-28 2014-10-02 Eberhard Karls Universität Tübingen Medizinische Fakultät Polyribonucleotid
EP3041938A1 (fr) * 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Polynucléotides circulaires
JP2017510542A (ja) * 2014-01-31 2017-04-13 ファクター バイオサイエンス インコーポレイテッド 核酸生成及び送達のための方法及び製品
WO2016036735A1 (fr) 2014-09-05 2016-03-10 The Johns Hopkins University Particules pénétrant à travers le mucus, à base de liposomes, pour une administration par voie muqueuse
EP3543339A1 (fr) * 2015-02-13 2019-09-25 Factor Bioscience Inc. Produits d'acides nucléiques et leurs procédés d'administration
BR112017018029B1 (pt) * 2015-03-20 2021-06-15 Unilever Ip Holdings B.V. Molécula de sirna, método para a redução da perspiração, composição antiperspirante e uso de uma composição antiperspirante
CA3045134A1 (fr) 2016-12-14 2018-06-21 Ligandal, Inc. Compositions et procedes d'administration de charge d'acide nucleique et/ou de proteine

Also Published As

Publication number Publication date
KR102901623B1 (ko) 2025-12-18
JP2025041910A (ja) 2025-03-26
AU2020232238A1 (en) 2021-09-23
PL3930676T3 (pl) 2023-01-23
IL285951A (en) 2021-10-31
US20220142896A1 (en) 2022-05-12
ES2928724T3 (es) 2022-11-22
JP7614108B2 (ja) 2025-01-15
AU2020232238B2 (en) 2025-10-30
IL285951B1 (en) 2024-04-01
IL285951B2 (en) 2024-08-01
WO2020180752A1 (fr) 2020-09-10
CN113543766A (zh) 2021-10-22
EP3930676B1 (fr) 2022-08-03
DK3930676T3 (en) 2022-10-31
EP3930676A1 (fr) 2022-01-05
JP2022522768A (ja) 2022-04-20
CA3128644A1 (fr) 2020-09-10
IL311628A (en) 2024-05-01
KR20210135529A (ko) 2021-11-15

Similar Documents

Publication Publication Date Title
MA55083A (fr) Polyribonucléotides et leurs utilisations cosmétiques
MA50618A (fr) Polyrhérapies et leurs utilisations
EP3810182A4 (fr) Néoantigènes et leurs utilisations
EP3891183A4 (fr) Anticorps anti-claudine et leurs utilisations
EP3625263A4 (fr) Anticorps anti-galectine-9 et leurs utilisations
EP3759143A4 (fr) Anticorps anti-tigit et leurs utilisations
EP3383916A4 (fr) Anticorps anti-cd73 et leurs utilisations
MA47789A (fr) Anticorps anti-phf-tau et leurs utilisations
EP3787607A4 (fr) Compositions de caroténoïdes et leurs utilisations
EP3902530A4 (fr) Nanovaccins polymères et leurs utilisations
EP3389702A4 (fr) Anticorps anti-lag-3 et leurs utilisations
EP3749315A4 (fr) Raltitrexed alpha-polyglutamaté et utilisations associées
EP3749318A4 (fr) Raltitrexed gamma-polyglutamaté et utilisations associées
EP4093768A4 (fr) Constructions cal-t et leurs utilisations
MA49886A (fr) Anticorps anti-par2 et leurs utilisations
EP3645563A4 (fr) Anticorps anti-fam19a5 et leurs utilisations
EP3538261A4 (fr) Catalyseurs en pérovskite et leurs utilisations
EP3720434A4 (fr) Mélanges non racémiques et leurs utilisations
EP3790586A4 (fr) Anticorps anti-dll3 et leurs utilisations
EP3655043A4 (fr) Compositions topiques et leurs utilisations
EP3432859A4 (fr) Compositions cosmétiques et leurs utilisations
EP3638251A4 (fr) Formulations de gel de bisphosphocine et leurs utilisations
EP3672987A4 (fr) Anticorps anti-apéline et leurs utilisations
EP3562508A4 (fr) Anticorps anti-lair1 et leurs utilisations
EP3850012A4 (fr) Anticorps anti-tnfrsf9 et leurs utilisations